Helicobacter pylori-negative / API2-MALT1 translocation-negative low-grade MALT lymphoma

Gastric Cancer. 2006;9(3):229-34. doi: 10.1007/s10120-006-0367-6.

Abstract

A 71-year-old man with a Helicobacter pylori infection-negative and API2-MALT1 translocation-negative extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type of the stomach has been followed conservatively for over 5 years. The lesion has shown no major morphological changes or malignant progression into a diffuse large-cell type during the time course. The absence of genetic translocation of API2-MALT1 was confirmed with fluorescence in situ hybridization (FISH). The prognosis of H. pylori-negative and API2-MALT1 translocation-negative low-grade MALT lymphoma is unknown, and a standard treatment for such lymphoma has yet to be defined. The case of MALT lymphoma negative for both of the above factors that we report has shown no obvious rapid progression or malignant change over the long-term course. Although curative operation and/or chemoradiotherapy should still be discussed as the treatment of choice, the treatment of this type of lymphoma must be carefully determined on a case-by-case basis, according to its biological status and prognosis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Gastroscopy / methods
  • Helicobacter pylori / isolation & purification*
  • Humans
  • Lymphoma, B-Cell, Marginal Zone / diagnosis*
  • Lymphoma, B-Cell, Marginal Zone / metabolism
  • Lymphoma, B-Cell, Marginal Zone / microbiology*
  • Lymphoma, Non-Hodgkin / diagnosis*
  • Lymphoma, Non-Hodgkin / genetics
  • Lymphoma, Non-Hodgkin / microbiology
  • Male
  • Oncogene Proteins, Fusion / genetics*
  • Stomach Neoplasms / diagnosis*
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / microbiology
  • Translocation, Genetic*

Substances

  • API2-MALT1 fusion protein, human
  • Oncogene Proteins, Fusion